ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,515
-0,44%
Bitcoin
59 878,02
-1,19%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Eli Lilly and Co (LLY)

  7. Eli Lilly and Co (LLY) Actualités

LLY

Eli Lilly (LLY)

Eli Lilly and Co
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:LLY
DateHeureSourceTitreSymboleSociété
30/04/202415h07IH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:LLYEli Lilly and Co
30/04/202413h59IH Market NewsU.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate DecisionNYSE:LLYEli Lilly and Co
30/04/202413h55IH Market NewsHSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in EarningsNYSE:LLYEli Lilly and Co
30/04/202412h45PR Newswire (US)Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline MomentumNYSE:LLYEli Lilly and Co
17/04/202412h15PR Newswire (US)Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesityNYSE:LLYEli Lilly and Co
16/04/202416h00PR Newswire (US)Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results AnnouncementNYSE:LLYEli Lilly and Co
03/04/202413h12IH Market NewsCal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and MoreNYSE:LLYEli Lilly and Co
11/03/202421h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
11/03/202421h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
10/03/202421h00PR Newswire (US)More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab studyNYSE:LLYEli Lilly and Co
08/03/202412h45PR Newswire (US)U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of DonanemabNYSE:LLYEli Lilly and Co
07/03/202414h00PR Newswire (US)Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity CareNYSE:LLYEli Lilly and Co
05/03/202423h00PR Newswire (US)Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual MeetingNYSE:LLYEli Lilly and Co
20/02/202416h00PR Newswire (US)Lilly to Participate in Cowen's 44th Annual Health Care ConferenceNYSE:LLYEli Lilly and Co
13/02/202423h04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:LLYEli Lilly and Co
09/02/202417h56Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
09/02/202415h30PR Newswire (US)Philip Johnson to Retire as Lilly TreasurerNYSE:LLYEli Lilly and Co
08/02/202422h51Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:LLYEli Lilly and Co
07/02/202423h08Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:LLYEli Lilly and Co
06/02/202412h45PR Newswire (US)Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 GuidanceNYSE:LLYEli Lilly and Co
06/02/202412h27IH Market NewsUS Index Futures Mixed, Oil Prices Edge HigherNYSE:LLYEli Lilly and Co
29/01/202412h09IH Market NewsPhilips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and latest newsNYSE:LLYEli Lilly and Co
29/01/202412h09IH Market NewsPhilips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and more Wall Street HighlightsNYSE:LLYEli Lilly and Co
25/01/202414h45Dow Jones NewsEli Lilly Executive VP of Global Quality Johna Norton to RetireNYSE:LLYEli Lilly and Co
25/01/202414h00PR Newswire (US)Johna Norton to Retire as Lilly Executive Vice President of Global QualityNYSE:LLYEli Lilly and Co
23/01/202418h00PR Newswire (US)Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter MeetingNYSE:LLYEli Lilly and Co
23/01/202416h00PR Newswire (US)Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial GuidanceNYSE:LLYEli Lilly and Co
22/01/202411h48IH Market NewsWall Street Highlights: Sony Abandons Billion-Dollar Merger, SolarEdge Announces 16% Workforce Reduction, and MoreNYSE:LLYEli Lilly and Co
10/01/202414h45InvestorsHub NewsWireGLP-1: Beyond Diabetes, a Blockbuster Horizon BeckonsNYSE:LLYEli Lilly and Co
05/01/202416h39Dow Jones NewsTrending: Lilly Launches Direct-to-Consumer WebsiteNYSE:LLYEli Lilly and Co
 Showing the most relevant articles for your search:NYSE:LLY

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
SPI
SP500
S&P 500
EU
CAP
Capgemini
NYSE
NKE
Nike
EU
LR
Legrand
EU
CS
Axa
EU
ML
Michelin
EU
AI
Air Liquide
NYSE
KO
Coca Cola
EU
GLE
Societe Generale
USI
USTECH100
US Tech 100
EU
PX4
SBF 120
EU
VIV
Vivendi
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés